C. Zacker

发表

Perspectives on electronic medical records adoption: electronic medical records (EMR) in outcomes research.

C. Mullins, D. Belletti, C. Zacker, 2010, Patient related outcome measures.

Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?

B. Stuart, T. Shaffer, C. Zacker, 2010, Health affairs.

A Systematic Review of the Effect of Cancer Treatment on Work Productivity of Patients and Caregivers.

M. Bhosle, C. Zacker, J. Covvey, 2017, Journal of managed care & specialty pharmacy.

The impact of pamidronate on inpatient and outpatient services among metastatic breast cancer patients

K. Beusterien, C. Zacker, S. Ackerman, 2001, Supportive Care in Cancer.

Use of health-related quality of life information in managed care formulary decision-making.

C. Zacker, W. Wu, R. Sause, 2005, Research in social & administrative pharmacy : RSAP.

Barriers and facilitators to shared decision-making in oncology: a systematic review of the literature

C. Zacker, E. Heidari, J. Covvey, 2019, Supportive Care in Cancer.

Results of the CAPPS: COPD – Assessment of Practice in Primary Care Study

D. Belletti, C. Zacker, J. Wogen, 2013, Current medical research and opinion.

A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease

K. Schulman, C. Zacker, J. Timbie, 2001, Supportive Care in Cancer.

Impact of Part D on previously uninsured Medicare beneficiaries with hypertension

B. Stuart, C. Zacker, A. Davidoff, 2012 .

Hypertension Treatment and Control Among 28 Physician Practices Across the United States: Results of the Hypertension: Assessment of Treatment to Target (HATT) Study

D. Belletti, C. Zacker, J. Wogen, 2010, Journal of clinical hypertension.

Correlates of hypertension control in a primary care setting.

N. Madden, D. Belletti, C. Zacker, 2004, American journal of hypertension.

Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.

Ahva Shahabi, C. Zacker, J. Baumgardner, 2018, Journal of oncology practice.

Anticipating Part D Phase Changes: How Heart Failure Patients Respond to the Medicare Drug Benefit Design

L. Magder, B. Stuart, T. Shaffer, 2014 .

Absenteeism among employees with irritable bowel syndrome.

A. Chawla, Shaohung S. Wang, C. Zacker, 2004, Managed care interface.

Irritable bowel syndrome: toward a cost-effective management approach.

C. Zacker, R. Martin, J. Barron, 2001, The American journal of managed care.

The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers

J. Doctor, K. Batt, C. Zacker, 2019, MDM policy & practice.

L. Kleinman, L. Frank, G. Ciesla, 2002, Clinical therapeutics.

The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study.

C. Zacker, S. Huber, R. Arbuckle, 2000, The oncologist.

Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States

D. Belletti, C. Zacker, J. Wogen, 2010, Cardiovascular diabetology.

Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study

M. Chisholm-Burns, C. Zacker, K. Demissie, 2013, BMC Nephrology.

The reliability and validity of the impact on lifestyle questionnaire in patients with acromegaly.

C. Pashos, E. Tafesse, C. Zacker, 2000, Value in Health.

Predictors of first-fill adherence for patients with hypertension.

W. Stewart, N. Shah, A. Schoenthaler, 2009, American journal of hypertension.

Intensified Diabetes Care Monitoring and Physician Education

D. Belletti, C. Zacker, A. Donnelly, 2008 .

Does an increase in non‐antihypertensive pill burden reduce adherence with antihypertensive drug therapy?

B. Stuart, I. Zuckerman, C. Zacker, 2012 .

Who bears the burden of Medicaid drug copayment policies?

B. Stuart, C. Zacker, B Stuart, 1999, Health affairs.

Institutional and contingency approaches to the reprofessionalization of pharmacy.

C. Zacker, L. Mucha, 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Cost of treating an episode of variceal bleeding in a VA setting

M. Helfand, C. Zacker, A. Zaman, 2000, American Journal of Gastroenterology.

Factors Associated with First-Fill Adherence Rates for Diabetic Medications: A Cohort Study

W. Stewart, N. Shah, C. Zacker, 2009, Journal of general internal medicine.

Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.

Anand A. Dalal, D. Brixner, J. Biskupiak, 2019, Journal of managed care & specialty pharmacy.

The impact of self‐ and physician‐administered cancer treatment on work productivity and healthcare utilization

S. Seabury, M. Frasco, C. Zacker, 2017, Research in social & administrative pharmacy : RSAP.

Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013.

B. Stuart, D. Qato, C. Zacker, 2018, The American journal of managed care.

Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations

S. Desselle, C. Zacker, P. Rane, 2009 .

Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes

Ahva Shahabi, C. Zacker, J. Baumgardner, 2018, Journal of managed care & specialty pharmacy.

Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States

D. Belletti, C. Zacker, J. Wogen, 2010, Cardiovascular diabetology.